All In Biotech

Investigational drug · Phase 3

Semagludtide

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Obesity & Overweight, Early Alzheimer's Disease.

Phase 3

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

1 still active

All registered trials

3

Any phase or sponsor naming "Semagludtide"

First trial start

2021

May 18, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Semagludtide", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Obesity & Overweight
  • Early Alzheimer's Disease

Approved drugs for the same conditions: Obesity and weight management · Alzheimer's disease · Cardiovascular and metabolic · Neurology

Largest trials

Live from ClinicalTrials.gov: studies naming "Semagludtide" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Obesity & Overweight

  • BofanglutideGZR18, BofanglutidaPhase 311 trials

    Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM), Obstructive Sleep Apnea (OSA), Obesity/Overweight in Adult

  • UBT251Phase 310 trials

    The United Bio-Technology (Hengqin) Co., Ltd. · Obesity, Obesity &Amp; Overweight, Diabetes Mellitus, Type 2

  • LUM-201Phase 36 trials

    Lumos Pharma · Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity & Overweight

  • HDM1005 1Phase 34 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Obesity & Overweight

  • HDM1005 2Phase 34 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Obesity & Overweight

  • EnobosarmPhase 22 trials

    Veru Inc. · Obesity & Overweight, Mobility Disability, HOMA-IR

  • BIO101Phase 21 trial

    Biophytis · Muscle Wasting, Obesity & Overweight, Obesity

  • ERX1000Phase 21 trial

    ERX Pharmaceuticals · Obesity & Overweight

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.